HOT-17


HOT-17, also known as 4-sec-butylthio-2,5-dimethoxy-N-hydroxyphenethylamine or as N-hydroxy-2C-T-17, is a psychedelic drug of the phenethylamine, 2C, and HOT-x families. It is the N-hydroxy derivative of 2C-T-17. The drug is taken orally.

Use and effects

In his book PiHKAL, Alexander Shulgin lists HOT-17's dose range as 70 to 120mg orally and its duration as 12 to 18hours. The drug's onset is 30minutes to 1.5hours and peak effects occur after 3hours. HOT-17's properties are very similar to those of 2C-T-17, which has a dose of 60 to 100mg orally, a duration of 10 to 15hours, and an onset of 1hour with a time to peak of 3hours. HOT-17 may act as a prodrug of 2C-T-17.
The effects of HOT-17 have been reported to include "something going on upstairs", no sensory distortion, mild time distortion, feeling light and slightly floaty, walking feeling pleasant due to the lightness, and no body load, among others. It was described as producing "plus-two" and "plus-three" experiences on the Shulgin Rating Scale. The compound is said to have an "unbelievably grim taste—not bitter, but simply evil".

Interactions

Chemistry

Synthesis

The chemical synthesis of HOT-17 has been described.

Analogues

s of HOT-17 include 2C-T-17, HOT-2, and HOT-7, among others.

History

HOT-17 was first described in the literature by Alexander Shulgin in his 1991 book PiHKAL.

Society and culture

Legal status

Canada

HOT-17 is a controlled substance in Canada under phenethylamine blanket-ban language.